191 related articles for article (PubMed ID: 33061459)
1. lncRNAHIF1A-AS2 Promotes Renal Carcinoma Cell Proliferation and Migration via miR-130a-5p/ERBB2 Pathway.
Zhu Y; Yang Z; Chen H; Pan Y; Gong L; Chen F; Jin X; Wen S; Li Y; Chen G
Onco Targets Ther; 2020; 13():9807-9820. PubMed ID: 33061459
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA.
Chen M; Wei X; Shi X; Lu L; Zhang G; Huang Y; Hou J
Cancer Biol Med; 2021 Mar; 18(2):587-603. PubMed ID: 33710813
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA HIF1A-AS2 Promotes Non-Small Cell Lung Cancer Progression by the miR-153-5p/S100A14 Axis.
Zhang W; Liu K; Pei Y; Tan J; Ma J; Zhao J
Onco Targets Ther; 2020; 13():8715-8722. PubMed ID: 32922043
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a sponge of miR-129-5p.
Wang X; Peng L; Gong X; Zhang X; Sun R
Aging (Albany NY); 2019 Dec; 11(24):11803-11813. PubMed ID: 31866584
[TBL] [Abstract][Full Text] [Related]
5. HIF1A-AS2 Promotes the Proliferation and Metastasis of Gastric Cancer Cells Through miR-429/PD-L1 Axis.
Mu L; Wang Y; Su H; Lin Y; Sui W; Yu X; Lv Z
Dig Dis Sci; 2021 Dec; 66(12):4314-4325. PubMed ID: 33555514
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma.
Lin H; Zhao Z; Hao Y; He J; He J
Biochem Cell Biol; 2020 Apr; 98(2):284-292. PubMed ID: 31626739
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.
Lin J; Shi Z; Yu Z; He Z
Biomed Pharmacother; 2018 Feb; 98():433-439. PubMed ID: 29278853
[TBL] [Abstract][Full Text] [Related]
8. LncRNA
Zhang Y; Ma H
J Thorac Dis; 2023 Mar; 15(3):1289-1301. PubMed ID: 37065560
[TBL] [Abstract][Full Text] [Related]
9. LncRNA PTOV1-AS2 Promotes Colon Cancer Progression through the miR-145-5p/FSCN1 Axis.
Zhang Z; Wu H; Chen Z; Li G; Guo J
J Oncol; 2023; 2023():1298312. PubMed ID: 36960218
[TBL] [Abstract][Full Text] [Related]
10. HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p/IL-6/STAT3 axis.
Si J; Ma Y; Lv C; Hong Y; Tan H; Yang Y
Mol Ther Nucleic Acids; 2021 Dec; 26():613-624. PubMed ID: 34703647
[TBL] [Abstract][Full Text] [Related]
11. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma.
Li X; Wu Y; Xiao Z; Liu Y; Wang C; Zhou L; Yang X
Pathol Res Pract; 2024 Jan; 253():154984. PubMed ID: 38064865
[TBL] [Abstract][Full Text] [Related]
14. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
15. LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.
Liang C; Pang L; Ke Y; Ji W; Xiong J; Ding R; Ding Y
Int J Clin Exp Pathol; 2019; 12(11):4011-4023. PubMed ID: 31933797
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HIF1A-AS2 facilitates adipose-derived stem cells (ASCs) osteogenic differentiation through miR-665/IL6 axis via PI3K/Akt signaling pathway.
Wu R; Ruan J; Sun Y; Liu M; Sha Z; Fan C; Wu Q
Stem Cell Res Ther; 2018 Dec; 9(1):348. PubMed ID: 30545407
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia.
Hu M; Fu Q; Jing C; Zhang X; Qin T; Pan Y
Biomed Pharmacother; 2020 May; 125():109703. PubMed ID: 32062551
[TBL] [Abstract][Full Text] [Related]
19. The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivo.
Guo X; Lee S; Cao P
Onco Targets Ther; 2019; 12():825-834. PubMed ID: 30774370
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p.
Yang Y; Xun N; Wu JG
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6971-6982. PubMed ID: 31486497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
